Skip to main content
. 2022 Sep 22;14(19):4595. doi: 10.3390/cancers14194595

Figure 3.

Figure 3

Correlation of GNL3L with cancer molecular subtypes and clinical stages. (A) GNL3L expression correlated with molecular subtypes in ACC, BRCA, ESCA, COAD, KIRP, LGG, LIHC, PRAD, and STAD. (B) Obvious discrepancy in GNL3L expression in dissimilar clinical stages in COAD, HNSC, KIRC, KIRP, MESO, and SKCM cancers. * p < 0.05; ** p < 0.01.